PT792275E - Promedicamento antiviral melhorado - Google Patents
Promedicamento antiviral melhoradoInfo
- Publication number
- PT792275E PT792275E PT95940014T PT95940014T PT792275E PT 792275 E PT792275 E PT 792275E PT 95940014 T PT95940014 T PT 95940014T PT 95940014 T PT95940014 T PT 95940014T PT 792275 E PT792275 E PT 792275E
- Authority
- PT
- Portugal
- Prior art keywords
- average
- improved antiviral
- antiviral
- improved
- phosphonoacids
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title abstract 2
- 241000701022 Cytomegalovirus Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4062—Esters of acids containing the structure -C(=X)-P(=X)(XR)2 or NC-P(=X)(XR)2, (X = O, S, Se)
- C07F9/4065—Esters of acids containing the structure -C(=X)-P(=X)(XR)2, (X = O, S, Se)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4075—Esters with hydroxyalkyl compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/340,161 US5696277A (en) | 1994-11-15 | 1994-11-15 | Antiviral prodrugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT792275E true PT792275E (pt) | 2004-09-30 |
Family
ID=23332146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT95940014T PT792275E (pt) | 1994-11-15 | 1995-11-15 | Promedicamento antiviral melhorado |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US5696277A (pt) |
| EP (1) | EP0792275B1 (pt) |
| JP (1) | JPH10508858A (pt) |
| AT (1) | ATE260926T1 (pt) |
| AU (1) | AU700651B2 (pt) |
| CA (1) | CA2205136C (pt) |
| DE (1) | DE69532642T2 (pt) |
| DK (1) | DK0792275T3 (pt) |
| ES (1) | ES2217287T3 (pt) |
| PT (1) | PT792275E (pt) |
| WO (1) | WO1996015132A1 (pt) |
Families Citing this family (78)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6458772B1 (en) | 1909-10-07 | 2002-10-01 | Medivir Ab | Prodrugs |
| US20020120130A1 (en) | 1993-09-10 | 2002-08-29 | Gilles Gosselin | 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents |
| US5696277A (en) * | 1994-11-15 | 1997-12-09 | Karl Y. Hostetler | Antiviral prodrugs |
| PT831852E (pt) | 1995-06-07 | 2007-02-28 | Uab Research Foundation | Nucleósidos com actividade anti-vírus da hepatite b |
| TW343975B (en) * | 1995-12-15 | 1998-11-01 | Boehringer Mannheim Gmbh | New phospholipid derivatives of phosphonocarboxylic acids, the production thereof as well as their use as antiviral pharmaceutical agents |
| SE9603726D0 (sv) * | 1996-10-11 | 1996-10-11 | Astra Ab | Novel compounds |
| SE9604582D0 (sv) * | 1996-12-13 | 1996-12-13 | Astra Ab | Novel compounds |
| US6686462B2 (en) | 1997-02-28 | 2004-02-03 | The Regents Of The University Of California | Antiviral compounds and methods of administration |
| US6126965A (en) * | 1997-03-21 | 2000-10-03 | Georgetown University School Of Medicine | Liposomes containing oligonucleotides |
| US7262173B2 (en) * | 1997-03-21 | 2007-08-28 | Georgetown University | Chemosensitizing with liposomes containing oligonucleotides |
| US20030229040A1 (en) * | 1997-03-21 | 2003-12-11 | Georgetown University | Cationic liposomal delivery system and therapeutic use thereof |
| US6559129B1 (en) * | 1997-03-21 | 2003-05-06 | Georgetown University | Cationic liposomal delivery system and therapeutic use thereof |
| WO1999043691A1 (en) | 1998-02-25 | 1999-09-02 | Emory University | 2'-fluoronucleosides |
| WO1999051613A1 (en) * | 1998-04-03 | 1999-10-14 | Medivir Ab | Prodrugs of phosphorous-containing pharmaceuticals |
| US6444837B1 (en) * | 1998-07-13 | 2002-09-03 | University Of Southern California | Synthesis and antiviral activity of a series of pyrophosphate analogs |
| PT2415776T (pt) | 1998-08-10 | 2016-07-07 | Novartis Ag | Beta-l-2'-desoxi-nucleosidos para o tratamento da hepatite b |
| US6444652B1 (en) | 1998-08-10 | 2002-09-03 | Novirio Pharmaceuticals Limited | β-L-2'-deoxy-nucleosides for the treatment of hepatitis B |
| DE69939604D1 (de) | 1998-11-02 | 2008-10-30 | Gilead Sciences Inc | Kombinationstherapie zur Behandlung von Hepatitis B Infektionen |
| CA2395430A1 (en) * | 1999-12-29 | 2001-07-05 | The Regents Of The University Of California | Treatment of drug-resistant human immunodeficiency virus infection |
| RU2265439C2 (ru) * | 2000-01-04 | 2005-12-10 | Де Риджентс Ов Де Юниверсити Ов Калифорния | Лечение инфекции вируса иммунодефицита человека с лекарственной устойчивостью |
| CA2405502A1 (en) | 2000-03-29 | 2001-10-04 | Georgetown University | Method of treating hepatitis delta viral infection |
| MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
| EP1736478B1 (en) | 2000-05-26 | 2015-07-22 | IDENIX Pharmaceuticals, Inc. | Methods and compositions for treating flaviviruses and pestiviruses |
| US6787526B1 (en) | 2000-05-26 | 2004-09-07 | Idenix Pharmaceuticals, Inc. | Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides |
| US6875751B2 (en) | 2000-06-15 | 2005-04-05 | Idenix Pharmaceuticals, Inc. | 3′-prodrugs of 2′-deoxy-β-L-nucleosides |
| WO2002032920A2 (en) | 2000-10-18 | 2002-04-25 | Pharmasset Limited | Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| WO2002087500A2 (en) * | 2001-04-27 | 2002-11-07 | Newbiotics, Inc. | Viral enzyme activated prototoxophores and use of same to treat viral infections |
| EP1435974A4 (en) | 2001-09-28 | 2006-09-06 | Idenix Cayman Ltd | METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEPATITIS C VIRUS USING 4 'MODIFIED NUCLEOSIDES |
| NZ537662A (en) | 2002-06-28 | 2007-10-26 | Idenix Cayman Ltd | 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| CN1678326A (zh) | 2002-06-28 | 2005-10-05 | 埃迪尼克斯(开曼)有限公司 | 用于治疗黄病毒感染的2'－c－甲基－3'－o－l－缬氨酸酯核糖呋喃基胞苷 |
| TW200500375A (en) | 2002-06-28 | 2005-01-01 | Idenix Cayman Ltd | Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae |
| US7608600B2 (en) * | 2002-06-28 | 2009-10-27 | Idenix Pharmaceuticals, Inc. | Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections |
| TWI244393B (en) | 2002-08-06 | 2005-12-01 | Idenix Pharmaceuticals Inc | Crystalline and amorphous forms of beta-L-2'-deoxythymidine |
| EP1572095B1 (en) | 2002-09-13 | 2015-06-10 | Novartis AG | Beta-l-2'-deoxynucleosides for use in the treatment of resistant hbv strains |
| CA2499036A1 (en) * | 2002-09-24 | 2004-04-08 | Koronis Pharmaceuticals, Incorporated | 1,3,5-triazines for treatment of viral diseases |
| US20070207973A1 (en) * | 2002-09-24 | 2007-09-06 | Koronis Pharmaceuticals, Incorporated | 1,3,5-Triazines for Treatment of Viral Diseases |
| LT1576138T (lt) | 2002-11-15 | 2017-06-26 | Idenix Pharmaceuticals Llc | 2`-šakoti nukleozidai derinyje su interferonu ir flaviviridae mutacija |
| AU2003300901A1 (en) | 2002-12-12 | 2004-06-30 | Idenix (Cayman) Limited | Process for the production of 2'-branched nucleosides |
| NZ540913A (en) * | 2002-12-23 | 2008-02-29 | Idenix Cayman Ltd | Process for the production of 3'-nucleoside prodrugs |
| HUE029877T2 (en) | 2003-05-30 | 2017-04-28 | Gilead Pharmasset Llc | Modified fluorinated nucleoside analogues |
| US20050075309A1 (en) | 2003-07-25 | 2005-04-07 | Richard Storer | Purine nucleoside analogues for treating Flaviviridae including hepatitis C |
| WO2005045310A2 (en) * | 2003-10-27 | 2005-05-19 | Wimberly Randal L | Dual reflector system |
| WO2005090370A1 (en) | 2004-02-05 | 2005-09-29 | The Regents Of The University Of California | Pharmacologically active agents containing esterified phosphonates and methods for use thereof |
| MXPA06011219A (es) | 2004-03-29 | 2007-05-08 | Univ South Florida | Tratamiento efectivo de tumores y cancer con triciribina y compuestos relacionados. |
| CA2571675A1 (en) * | 2004-06-23 | 2006-01-05 | Idenix (Cayman) Limited | 5-aza-7-deazapurine derivatives for treating infections with flaviviridae |
| CN101023094B (zh) | 2004-07-21 | 2011-05-18 | 法莫赛特股份有限公司 | 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备 |
| US8492539B2 (en) | 2004-09-14 | 2013-07-23 | Gilead Pharmasset Llc | Preparation of 2′-fluoro-2′-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives |
| TW200628161A (en) * | 2004-11-12 | 2006-08-16 | Panacos Pharmaceuticals Inc | Novel betulin derivatives, preparation thereof and use thereof |
| JP4516863B2 (ja) * | 2005-03-11 | 2010-08-04 | 株式会社ケンウッド | 音声合成装置、音声合成方法及びプログラム |
| US8642577B2 (en) * | 2005-04-08 | 2014-02-04 | Chimerix, Inc. | Compounds, compositions and methods for the treatment of poxvirus infections |
| EP2842559A3 (en) | 2005-04-08 | 2015-03-18 | Chimerix, Inc. | Compounds, compositions and methods for the treatment of viral infections and other medical disorders |
| EA200800932A1 (ru) | 2005-09-26 | 2008-10-30 | Фармассет, Инк. | Модифицированные 4`-нуклеозиды в качестве противовирусных агентов |
| ES2422290T3 (es) | 2005-12-23 | 2013-09-10 | Idenix Pharmaceuticals Inc | Procedimiento para preparar un producto intermedio sintético para la preparación de nucleósidos ramificados |
| US8895531B2 (en) | 2006-03-23 | 2014-11-25 | Rfs Pharma Llc | 2′-fluoronucleoside phosphonates as antiviral agents |
| US20080039428A1 (en) * | 2006-06-29 | 2008-02-14 | Panacos Pharmaceuticals, Inc. | Antiretroviral combination therapy |
| US7950880B2 (en) * | 2006-10-18 | 2011-05-31 | Kennametal Inc. | Spiral flute tap |
| US7964580B2 (en) | 2007-03-30 | 2011-06-21 | Pharmasset, Inc. | Nucleoside phosphoramidate prodrugs |
| ES2572631T3 (es) | 2008-01-25 | 2016-06-01 | Chimerix, Inc. | Métodos de tratamiento de infecciones virales |
| WO2009129120A2 (en) | 2008-04-15 | 2009-10-22 | Rfs Pharma, Llc | Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections |
| AU2009329872B2 (en) | 2008-12-23 | 2016-07-07 | Gilead Pharmasset Llc | Synthesis of purine nucleosides |
| PA8855601A1 (es) | 2008-12-23 | 2010-07-27 | Forformidatos de nucleósidos | |
| NZ593649A (en) | 2008-12-23 | 2013-11-29 | Gilead Pharmasset Llc | Nucleoside analogs |
| TWI583692B (zh) | 2009-05-20 | 2017-05-21 | 基利法瑪席特有限責任公司 | 核苷磷醯胺 |
| US8618076B2 (en) | 2009-05-20 | 2013-12-31 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
| WO2011011519A1 (en) | 2009-07-21 | 2011-01-27 | Chimerix, Inc. | Compounds, compositions and methods for treating ocular conditions |
| US9006218B2 (en) | 2010-02-12 | 2015-04-14 | Chimerix Inc. | Nucleoside phosphonate salts |
| CA2797601A1 (en) | 2010-04-26 | 2011-11-10 | Chimerix, Inc. | Methods of treating retroviral infections and related dosage regimes |
| CA2818853A1 (en) | 2010-11-30 | 2012-06-07 | Gilead Pharmasset Llc | 2'-spirocyclo-nucleosides for use in therapy of hcv or dengue virus |
| US8889159B2 (en) | 2011-11-29 | 2014-11-18 | Gilead Pharmasset Llc | Compositions and methods for treating hepatitis C virus |
| ES3018133T3 (en) | 2011-11-30 | 2025-05-14 | Univ Emory | Jak inhibitors for use in the prevention or treatment of a viral disease caused by a coronaviridae |
| SG10201800188SA (en) | 2013-03-15 | 2018-02-27 | Univ California | Acyclic nucleoside phosphonate diesters |
| PT3038601T (pt) | 2013-08-27 | 2020-06-30 | Gilead Pharmasset Llc | Formulação combinada de dois compostos antivirais |
| CN111808136B (zh) | 2014-09-15 | 2024-06-11 | 加利福尼亚大学董事会 | 核苷酸类似物 |
| EP3350191B9 (en) | 2015-09-15 | 2021-12-22 | The Regents of the University of California | Nucleotide analogs |
| WO2018023054A1 (en) * | 2016-07-28 | 2018-02-01 | Kansas State University Research Foundation | Protease transition state inhibitor prodrugs |
| WO2020006050A1 (en) * | 2018-06-26 | 2020-01-02 | Tsrl, Inc. | Metabolically stable prodrugs |
| WO2021035214A1 (en) | 2019-08-22 | 2021-02-25 | Emory University | Nucleoside prodrugs and uses related thereto |
| KR20250052378A (ko) | 2022-07-21 | 2025-04-18 | 안티바 바이오사이언시즈, 인크. | Hpv 감염 및 hpv-유도 신생물의 치료를 위한 조성물 및 투여 형태 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7607496L (sv) * | 1976-07-01 | 1978-01-02 | Astra Laekemedel Ab | Sett for bekempning av virusinfektioner |
| CA1140049A (en) * | 1977-12-22 | 1983-01-25 | Dke J.E. Helgstran | Pharmaceutical preparations from derivatives of hydroxycarbonylphosphonic acid |
| US5072032A (en) * | 1989-06-21 | 1991-12-10 | Mckenna Charles E | Preparation and use of thiophosphonates and thio-analogues of phosphonoformic acid |
| US5411947A (en) * | 1989-06-28 | 1995-05-02 | Vestar, Inc. | Method of converting a drug to an orally available form by covalently bonding a lipid to the drug |
| US5194654A (en) * | 1989-11-22 | 1993-03-16 | Vical, Inc. | Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
| EP0673256A4 (en) * | 1992-12-09 | 1997-01-29 | Indiana University Foundation | SUPPRESSION OF MYELOID CELLS. |
| US5696277A (en) * | 1994-11-15 | 1997-12-09 | Karl Y. Hostetler | Antiviral prodrugs |
-
1994
- 1994-11-15 US US08/340,161 patent/US5696277A/en not_active Expired - Lifetime
-
1995
- 1995-11-15 PT PT95940014T patent/PT792275E/pt unknown
- 1995-11-15 WO PCT/US1995/014940 patent/WO1996015132A1/en not_active Ceased
- 1995-11-15 AU AU41635/96A patent/AU700651B2/en not_active Ceased
- 1995-11-15 AT AT95940014T patent/ATE260926T1/de not_active IP Right Cessation
- 1995-11-15 CA CA002205136A patent/CA2205136C/en not_active Expired - Fee Related
- 1995-11-15 DE DE69532642T patent/DE69532642T2/de not_active Expired - Lifetime
- 1995-11-15 DK DK95940014T patent/DK0792275T3/da active
- 1995-11-15 JP JP8516340A patent/JPH10508858A/ja active Pending
- 1995-11-15 EP EP95940014A patent/EP0792275B1/en not_active Expired - Lifetime
- 1995-11-15 ES ES95940014T patent/ES2217287T3/es not_active Expired - Lifetime
-
1997
- 1997-12-08 US US08/986,881 patent/US6002029A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69532642D1 (de) | 2004-04-08 |
| DK0792275T3 (da) | 2004-07-05 |
| US6002029A (en) | 1999-12-14 |
| ATE260926T1 (de) | 2004-03-15 |
| JPH10508858A (ja) | 1998-09-02 |
| US5696277A (en) | 1997-12-09 |
| CA2205136C (en) | 2008-01-22 |
| EP0792275A1 (en) | 1997-09-03 |
| EP0792275B1 (en) | 2004-03-03 |
| EP0792275A4 (en) | 1998-02-25 |
| WO1996015132A1 (en) | 1996-05-23 |
| AU4163596A (en) | 1996-06-06 |
| AU700651B2 (en) | 1999-01-14 |
| CA2205136A1 (en) | 1996-05-23 |
| DE69532642T2 (de) | 2005-06-30 |
| ES2217287T3 (es) | 2004-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT792275E (pt) | Promedicamento antiviral melhorado | |
| DE69426904D1 (de) | Phosphonat-Nukleotid Ester-Derivate | |
| FI933656A7 (fi) | 2,4-diaminokinatsoliinijohdannaiset, jotka tehostavat kasvaintenvastai sta aktiivisuutta | |
| FI952861A7 (fi) | Absorboiva kertakäyttötuote, jossa on parannettu mekaaninen kiinnikesysteemi | |
| FI950257L (fi) | Imukykyisiä tuotteita, joissa on pikkuhousua peittävät komponentit, jotka sulkevat luonnollisella tavalla housun reunat sisäänsä | |
| FI951600L (fi) | Terapeuttinen HIV:n vastainen oligonukleotidi ja lääkeaine | |
| AU2156092A (en) | Use of polymerized hemoglobin to increase the antitumor effect of the ionizing radiation | |
| MX9202839A (es) | 4-aminoquinolinas y composiciones farmaceuticas de las mismas. | |
| FI940427L (fi) | Ihon läpi vaikuttavia terapeuttisia systeemejä | |
| DE69105160D1 (de) | Verriegelbare Schnalle. | |
| FI935517A7 (fi) | Fenoksi- ja fenoksialkyylipiperidiinejä virusvastaisina aineina | |
| DE69204228D1 (de) | Paar von vorderen und hinteren Reifen. | |
| KR930702893A (ko) | 상보시스템을 저해하거나 또는 면역활성을 억제하는 성분물 | |
| FR2591483B1 (fr) | Compositions pharmaceutiques antivirales et antitumorales. | |
| DE69328050D1 (de) | Rücklaufsperre | |
| DE69311862D1 (de) | Kontinuierliche Dispergiervorrichtung | |
| NO840104L (no) | Oksalkylerte polyamidoaminer, samt anvendelse av dem | |
| ITMI921235A1 (it) | Oligonucleotidi antisenso ad attivita' antitumorale, composizioni farmaceutiche che li comprendono, e loro impieghi | |
| DE69113026D1 (de) | Kontinuierliche Dispergiervorrichtung. | |
| FI950533L (fi) | Seco-nukleosidien liponulkeotidit, niiden valmistaminen sekä niiden käyttö virusten vastaisina lääkkeinä | |
| FI945672L (fi) | Elastosoleja, niiden valmistaminen käyttöä varten sekä niistä tehtyjä tuotteita | |
| ITMI912652A0 (it) | Medicamento ad attivita' antielasica | |
| ES1022839Y (es) | Bragas monouso. | |
| KR940006900U (ko) | 유아용 멜빵 | |
| AU1871592A (en) | Novel reference influenza viruses and antiviral drug susceptibility methods |